Showing results (461-470 of 4,868) with videos related to
Sort By:
Pageof 487
Urologic Oncology|March 15, 2011
Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimensYuji Kusuda, Hideaki Miyake, Hosny M Behnsawy, et al.Urologic Oncology|January 4, 2011
Combating unethical publications with plagiarism detection servicesH R GarnerUrologic Oncology|February 5, 2011
Prognostic influence of the third Gleason grade in prostatectomy specimensOderay Mabel Cedeño Díaz, María Jesús Fernández Aceñero, Emilio Alvarez FernándezUrologic Oncology|March 1, 2011
Telomerase mRNA detection in serum of patients with prostate cancerLuca Dalle Carbonare, Adriano Gasparetto, Luca Donatelli, et al.Urologic Oncology|January 13, 2011
Expression of cyclin DI in human prostate cancer cell linesY Chen, N M Navone, C J ContiUrologic Oncology|January 13, 2011
Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group studyD L Lamm, B A Blumenstein, E David Crawford, et al.Urologic Oncology|January 13, 2011
The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinomaK T Ow, H Mameghan, A Lochhead, et al.Urologic Oncology|January 13, 2011
A phase I study of FAP (5-Fluorouracil, α-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignanciesS M Tu, E D Robinson, R J Amato, et al.Urologic Oncology|January 13, 2011
Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancerJ L Osborn, G G Schwartz, D C Smith, et al.Urologic Oncology|January 13, 2011
Oncogenic transformation and growth factor production of a human urothelial cell lineH H Wang, S Robinson, J Melvillej, et al.Pageof 487